Invention Grant
- Patent Title: Sustained release pharmaceutical composition
- Patent Title (中): 持续释放药物组合物
-
Application No.: US10843005Application Date: 2004-05-10
-
Publication No.: US08128958B2Publication Date: 2012-03-06
- Inventor: Kazuhiro Sako , Toyohiro Sawada , Hiromu Kondo , Keiichi Yoshihara , Hiroyuki Kojima
- Applicant: Kazuhiro Sako , Toyohiro Sawada , Hiromu Kondo , Keiichi Yoshihara , Hiroyuki Kojima
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: JP2003-380448 20031110
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/16 ; A61K9/22 ; A61K9/50 ; A01N41/06 ; C07C303/00
Abstract:
The present invention provides a sustained-release pharmaceutical composition, characterized in that, there are contained tamsulosin or a pharmaceutically acceptable salt thereof and a carrier for a sustained-release pharmaceutical composition and the ratio (Cmin/Cmax ratio) of the plasma tamsulosin concentration at 24 hours after the administration of the preparation per os (Cmin) to the maximum plasma tamsulosin concentration after the administration (Cmax) is about 0.4 or more.
Public/Granted literature
- US20050100603A1 Sustained release pharmaceutical composition Public/Granted day:2005-05-12
Information query
